SCHEMBL22196103

SCHEMBL22196103

Bc1cc(C)c2ccccc2n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.64
BACE1 P56817 1/20 0.60
KDM4E B2RXH2 6/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
MAPT P10636 2/20 0.51
RAB9A P51151 2/20 0.51
POLB P06746 1/20 0.51
ALDH1A1 P00352 3/20 0.50
GAA P10253 3/20 0.50
NPFFR1 Q9GZQ6 1/20 0.50
NPFFR2 Q9Y5X5 1/20 0.50
SMN1; SMN2 Q16637 5/20 0.49
HPGD P15428 2/20 0.49
ACHE P22303 1/20 0.49
LMNA P02545 2/20 0.47
KMT2A Q03164 1/20 0.47
TP53 P04637 1/20 0.47
GPR3 P46089 1/20 0.47
NCF1 P14598 2/20 0.46
ADRB1 P08588 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1088580 0.78 CYP1A2 (0.69) CYP1A2BACE1KDM4EL3MBTL1MAPT
SCHEMBL89010 0.78 CYP1A2 (1.00) CYP1A2BACE1KDM4EL3MBTL1MAPT
SCHEMBL29502790 0.78 CYP1A2 (1.00) CYP1A2BACE1KDM4EL3MBTL1MAPT
Hydrochloric Acid SCHEMBL11674460 0.77 CYP1A2 (0.96) CYP1A2BACE1KDM4EL3MBTL1MAPT
SCHEMBL12997893 0.75 CYP1A2 (0.64) CYP1A2BACE1KDM4EL3MBTL1MAPT
SCHEMBL18544874 0.75 CYP1A2 (0.64) CYP1A2BACE1KDM4EL3MBTL1MAPT
SCHEMBL3070474 0.75 CYP1A2 (0.64) CYP1A2BACE1KDM4EL3MBTL1MAPT
SCHEMBL362901 0.75 CYP1A2 (0.64) CYP1A2BACE1KDM4EL3MBTL1MAPT
SCHEMBL832589 0.75 CYP1A2 (0.64) CYP1A2BACE1KDM4EL3MBTL1MAPT
SCHEMBL377555 0.75 CYP1A2 (0.64) CYP1A2BACE1KDM4EL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200216430-A1 CATALYST-FREE AND REDOX-NEUTRAL INNATE TRIFLUOROMETHYLATION AND ALKYLATION OF (HETERO)AROMATICS ENABLED BY LIGHT THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2020-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216430-A1 CATALYST-FREE AND REDOX-NEUTRAL INNATE TRIFLUOROMETHYLATION AND ALKYLATION OF (HETERO)AROMATICS ENABLED BY LIGHT CYBB, NOX4, NOX3 CYP1A2 172/4885BACE1 2802/4885KDM4E 2810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.